酮康唑（Ketoconazole） 用于 雄激素性脱发
A 证据 多项大型临床试验一致显示出显著的益处。基于17项研究（3项荟萃分析、2项RCT），共5,154名参与者。16/17项研究显示积极效果。
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dketoconazole\u0026condition\u003Dandrogenetic\u002Dalopecia';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
结论
Ketoconazole shampoo has strong evidence supporting its use for androgenetic alopecia, working through both antifungal and anti-androgenic mechanisms, and is recommended as a complement to other hair loss approaches.
- 16 out of 17 studies show positive effects across 5,154 participants
- Works through dual mechanisms: antifungal scalp benefits and local anti-androgenic activity
- Included in clinical guidelines as a complementary approach for pattern hair loss
- Typically used as a 1-2% shampoo applied 2-3 times per week
Key Study Findings
Review
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Dose: None
vs: None
Outcome: scalp microbiome alterations in androgenetic alopecia
效果: None
None
研究人群: patients with androgenetic alopecia
laboratory/in vitro
26 weeks
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line.
Dose: F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0.
vs: Placebo
效果: F1 and F3 stable for 180 days; F2 stable for 14 days; F4 and F5 stable for 150 days; F6/F7 stable fo
None
Review
A Canadian Consensus on Androgenetic Alopecia: Approach and Management.
Dose: None
vs: Placebo
效果: None
None
systematic review
Management of androgenic alopecia: a systematic review of the literature.
Dose: various across 141 included studies
vs: Placebo
效果: multiple treatments shown to successfully promote hair growth; superiority of multifaceted individua
None
Systematic Review
n=318
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Dose: None
vs: Placebo
效果: Increased hair shaft diameter; significant increase in pilary index; clinical improvement by photogr
None
narrative review
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
Dose: varies
vs: Placebo
效果: None
None
Key Statistics
19
研究数量
5154
受试者
↑
Positive
A
等级
Referenced Papers
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Review
International journal of …
2026
Journal of cutaneous …
2025
2 次引用
International journal of …
2025
Journal of cosmetic …
2024
11 次引用
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Systematic Review
Dermatologic therapy
2020
34 次引用
American journal of …
2020
24 次引用
Alternative therapies in …
2020
11 次引用
Topical ketoconazole: a systematic review of current dermatological applications and future developments.
Systematic Review
The Journal of …
2019
73 次引用
Pharmaceutics
2019
7 次引用
The Journal of …
2018
69 次引用
Female pattern hair loss.
Review
Current problems in …
2015
8 次引用
ISRN pharmacology
2014
22 次引用
Androgenetic alopecia.
Review
Giornale italiano di …
2014
8 次引用
International journal of …
2013
Skin therapy letter
2012
100 次引用
ISRN dermatology
2011
Clinics in dermatology
2010
Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity.
Other
Journal of dermatological …
2007
39 次引用
Georgian medical news
2007
The Journal of …
2005
24 次引用
Medical hypotheses
2004
21 次引用
The Journal of …
2002
96 次引用
International journal of …
2002
53 次引用
Dermatology (Basel, Switzerland)
1998
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- topical:
- 2% shampoo, 2-3x/week
上限： Topical only for hair loss
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Negative | -- |
| F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0. | 26 weeks | Positive | -- |
| None | -- | Positive | -- |
| various across 141 included studies | -- | Positive | -- |
| None | -- | Positive | 318 |
| varies | -- | Positive | -- |
| dutasteride and ketoconazole at pharmacokinetic study doses in rats (not specified in abstract) | -- | Mixed | -- |
| various topical ketoconazole formulations | -- | Positive | 4566 |
最佳服用时间： Lather on scalp and leave for 3-5 minutes before rinsing; use 2-3 times per week
Safety & Side Effects
已报告的副作用
- ⚠ Scalp dryness and irritation
- ⚠ Changes in hair texture
- ⚠ Oily or dry scalp (paradoxical)
- ⚠ Contact dermatitis (rare)
已知相互作用
- ● Other topical hair treatments (apply at separate times)
- ● Systemic ketoconazole has many interactions but topical has minimal systemic absorption
可耐受最高摄入量： Topical only for hair loss
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does 酮康唑（Ketoconazole） help with 雄激素性脱发?
Based on 19 studies with 5,154 participants, there is strong evidence from multiple clinical trials that 酮康唑（Ketoconazole） may support 雄激素性脱发 management. Our evidence grade is A (Strong Evidence).
How much 酮康唑（Ketoconazole） should I take for 雄激素性脱发?
Studies have used various dosages. A commonly studied range is 2% shampoo, 2-3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 酮康唑（Ketoconazole）?
Reported side effects may include Scalp dryness and irritation, Changes in hair texture, Oily or dry scalp (paradoxical), Contact dermatitis (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 酮康唑（Ketoconazole） and 雄激素性脱发?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 5,154 total participants. The overall direction of effect is positive.
Related Evidence
其他成分用于 雄激素性脱发
酮康唑（Ketoconazole） 用于其他健康状况
References
- [1] Aditya K Gupta et al.. Int J Dermatol. 2026. Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights. doi:10.1111/ijd.70365 PubMed
- [2] Ian Landells et al.. J Cutan Med Surg. 2025. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. doi:10.1177/12034754251368849 PubMed
- [3] Carolina Schettino Kegele et al.. Int J Pharm Compd. 2025. Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line. PubMed
- [4] Amanda Rosenthal et al.. J Cosmet Laser Ther. 2024. Management of androgenic alopecia: a systematic review of the literature. doi:10.1080/14764172.2024.2362126 PubMed
- [5] Jaime R Fields et al.. Dermatol Ther. 2020. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. doi:10.1111/dth.13202 PubMed
- [6] Dustin H Marks et al.. Am J Clin Dermatol. 2020. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. doi:10.1007/s40257-019-00493-z PubMed
- [7] Solmaz Asnaashari et al.. Altern Ther Health Med. 2020. Herbal Medicines For Treatment of Androgenic Alopecia. PubMed
- [8] Franchesca D Choi et al.. J Dermatolog Treat. 2019. Topical ketoconazole: a systematic review of current dermatological applications and future developments. doi:10.1080/09546634.2019.1573309 PubMed
- [9] Seong-Wook Seo et al.. Pharmaceutics. 2019. In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole. doi:10.3390/pharmaceutics11120673 PubMed
- [10] Motomu Manabe et al.. J Dermatol. 2018. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. doi:10.1111/1346-8138.14470 PubMed
- [11] Dimitrios Ioannides et al.. Curr Probl Dermatol. 2015. Female pattern hair loss. doi:10.1159/000369404 PubMed
- [12] Muhsin A Aldhalimi et al.. ISRN Pharmacol. 2014. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice. doi:10.1155/2014/575423 PubMed
- [13] B M Piraccini et al.. G Ital Dermatol Venereol. 2014. Androgenetic alopecia. PubMed
- [14] Lauren L Levy et al.. Int J Womens Health. 2013. Female pattern alopecia: current perspectives. doi:10.2147/IJWH.S49337 PubMed
- [15] K J McElwee et al.. Skin Therapy Lett. 2012. Promising therapies for treating and/or preventing androgenic alopecia. PubMed
- [16] A W Rafi et al.. ISRN Dermatol. 2011. Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. doi:10.5402/2011/241953 PubMed
- [17] Andreas D Katsambas et al.. Clin Dermatol. 2010. Hormonal therapy for acne: why not as first line therapy? facts and controversies. doi:10.1016/j.clindermatol.2009.03.006 PubMed
- [18] Shigeki Inui et al.. J Dermatol Sci. 2007. Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. doi:10.1016/j.jdermsci.2006.08.011 PubMed
- [19] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
- [20] Ju Jiang et al.. J Dermatol. 2005. Topical application of ketoconazole stimulates hair growth in C3H/HeN mice. doi:10.1111/j.1346-8138.2005.tb00756.x PubMed
- [21] B S Hugo Perez. Med Hypotheses. 2004. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. doi:10.1016/s0306-9877(03)00264-0 PubMed
- [22] Sujay Khandpur et al.. J Dermatol. 2002. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. doi:10.1111/j.1346-8138.2002.tb00314.x PubMed
- [23] C Piérard-Franchimont et al.. Int J Cosmet Sci. 2002. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. doi:10.1046/j.1467-2494.2002.00145.x PubMed
- [24] C Piérard-Franchimont et al.. Dermatology. 1998. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. doi:10.1159/000017954 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。